{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:46:21Z","timestamp":1759333581991},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1067\/mjd.2000.104790","type":"journal-article","created":{"date-parts":[[2003,12,31]],"date-time":"2003-12-31T12:36:45Z","timestamp":1072874205000},"page":"841-844","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"P1","title":["Antiepiligrin cicatricial pemphigoid"],"prefix":"10.1067","volume":"42","author":[{"given":"Roger Chin-Che","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelmira","family":"Lazarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Ghieh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ching","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Su","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2000.104790_bib1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1346-8138.1995.tb03931.x","article-title":"Studies of patients with anti-epiligrin cicatricial pemphigoid","volume":"22","author":"Yancey","year":"1995","journal-title":"J Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1365-2133.1997.19522044.x","article-title":"Anti-epiligrin (laminin 5) cicatricial pemphigoid and lung carcinoma: coincidence or association?","volume":"137","author":"Gibson","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archderm.1994.01690120057008","article-title":"Antiepiligrin cicatricial pemphigoid: a subepithelial bullous disorder","volume":"130","author":"Domloge-Hultsch","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/1523-1747.ep12337073","article-title":"Noncomplement fixing, IgG4 autoantibodies predominate in patients with anti-epiligrin cicatricial pemphigoid","volume":"109","author":"Hsu","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/1523-1747.ep12665840","article-title":"Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane","volume":"104","author":"Shimizu","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2133.1998.02502.x","article-title":"Anti-epiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5(\u03b13\u03b23\u03b32)","volume":"139","author":"Lazarova","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.1997.20002081.x","article-title":"Anti-epiligrin (laminin 5) cicatricial pemphigoid","volume":"137","author":"Allbritton","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib8","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1172\/JCI116033","article-title":"Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease","volume":"90","author":"Domloge-Hultsch","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1067\/mjd.2000.104790_bib9","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0190-9622(96)90086-9","article-title":"Antiepiligrin cicatricial pemphigoid: the first case report from Japan","volume":"34","author":"Hashimoto","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s001050050697","article-title":"Vernarbendes pemphigoid mit autoantik\u00f6rpern gegen laminin-5 (epiligrin) bei einer patientin mit metastasierendem endometriumkarzinom","volume":"49","author":"Lenz","year":"1998","journal-title":"Hautarzt"},{"key":"10.1067\/mjd.2000.104790_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0190-9622(96)90604-0","article-title":"Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol\/L salt-split skin","volume":"35","author":"Lazarova","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/1523-1747.ep12323431","article-title":"Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the \u03b1 subunit of laminin 5","volume":"105","author":"Kirtschig","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0092-8674(81)90115-X","article-title":"Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia","volume":"24","author":"Stanley","year":"1981","journal-title":"Cell"},{"key":"10.1067\/mjd.2000.104790_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/1523-1747.ep12513524","article-title":"A-431 cells and human keratinocytes synthesize and secrete the third component of complement","volume":"95","author":"Basset-Seguin","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib15","first-page":"682","article-title":"Anti-epiligrin cicatricial pemphigoid: a case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita","volume":"139","author":"Fujimoto","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib16","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archderm.1997.03890450048006","article-title":"Diagnostic value of indirect immunofluorescence of sodium chloride\u2013split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses","volume":"133","author":"Ghohestani","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archderm.135.2.173","article-title":"Anti-epiligrin cicatricial pemphigoid with antibodies against the gamma2 subunit of laminin 5","volume":"135","author":"Nousari","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.104790_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0161-6420(82)34791-0","article-title":"Immunosuppressive therapy for progressive ocular cicatricial pemphigoid","volume":"89","author":"Foster","year":"1982","journal-title":"Ophthalmology"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200700454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200700454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T23:14:20Z","timestamp":1712272460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962200700454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S0190962200700454"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.104790","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiepiligrin cicatricial pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2000.104790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}